111 – 120 of 341
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy : Results from the LAParoscopic Prostatectomy Robot Open Trial
(
- Contribution to journal › Article
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
(
- Contribution to journal › Article
-
Mark
A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.328-328(
- Contribution to journal › Article
- 2017
-
Mark
Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
(
- Contribution to journal › Article
-
Mark
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
(
- Contribution to journal › Article
-
Mark
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone : Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above
(
- Contribution to journal › Article
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article
-
Mark
Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer
(
- Contribution to journal › Article